
Malaria Vaccines Global Market Report 2025
Description
Malaria Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on malaria vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for malaria vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The malaria vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Agent: Plasmodium Falciparum; Plasmodium Vivax; Anopheles Species
2) By Vaccine Type: Pre-Erythrocytic; Erythrocytic; Multi-antigen; Other Vaccines
3) By Route Of Administration: Intramuscular; Subcutaneous; Intradermal; Other Routes
4) By Distribution Channel: Public; Private
Subsegments:
1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine; Other Experimental Vaccines
2) By Plasmodium Vivax: Candidate Vaccines In Development; Combination Vaccines
3) By Anopheles Species: Transmission-Blocking Vaccines; Vector Control Approaches
Companies Mentioned: Pfizer Inc.; Ipca Laboratories Ltd.; Novartis AG; Sanofi SA; GlaxoSmithKline Plc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
This report focuses on malaria vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for malaria vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The malaria vaccines market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Agent: Plasmodium Falciparum; Plasmodium Vivax; Anopheles Species
2) By Vaccine Type: Pre-Erythrocytic; Erythrocytic; Multi-antigen; Other Vaccines
3) By Route Of Administration: Intramuscular; Subcutaneous; Intradermal; Other Routes
4) By Distribution Channel: Public; Private
Subsegments:
1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine; Other Experimental Vaccines
2) By Plasmodium Vivax: Candidate Vaccines In Development; Combination Vaccines
3) By Anopheles Species: Transmission-Blocking Vaccines; Vector Control Approaches
Companies Mentioned: Pfizer Inc.; Ipca Laboratories Ltd.; Novartis AG; Sanofi SA; GlaxoSmithKline Plc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Malaria Vaccines Market Characteristics
- 3. Malaria Vaccines Market Trends And Strategies
- 4. Malaria Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Malaria Vaccines Growth Analysis And Strategic Analysis Framework
- 5.1. Global Malaria Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Malaria Vaccines Market Growth Rate Analysis
- 5.4. Global Malaria Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Malaria Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Malaria Vaccines Total Addressable Market (TAM)
- 6. Malaria Vaccines Market Segmentation
- 6.1. Global Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Plasmodium Falciparum
- Plasmodium Vivax
- Anopheles Species
- 6.2. Global Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pre-Erythrocytic
- Erythrocytic
- Multi-antigen
- Other Vaccines
- 6.3. Global Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Intramuscular
- Subcutaneous
- Intradermal
- Other Routes
- 6.4. Global Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Public
- Private
- 6.5. Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Falciparum, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- RTS,S/AS01 Vaccine
- Other Experimental Vaccines
- 6.6. Global Malaria Vaccines Market, Sub-Segmentation Of Plasmodium Vivax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Candidate Vaccines In Development
- Combination Vaccines
- 6.7. Global Malaria Vaccines Market, Sub-Segmentation Of Anopheles Species, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Transmission-Blocking Vaccines
- Vector Control Approaches
- 7. Malaria Vaccines Market Regional And Country Analysis
- 7.1. Global Malaria Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Malaria Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Malaria Vaccines Market
- 8.1. Asia-Pacific Malaria Vaccines Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Malaria Vaccines Market
- 9.1. China Malaria Vaccines Market Overview
- 9.2. China Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Malaria Vaccines Market
- 10.1. India Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Malaria Vaccines Market
- 11.1. Japan Malaria Vaccines Market Overview
- 11.2. Japan Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Malaria Vaccines Market
- 12.1. Australia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Malaria Vaccines Market
- 13.1. Indonesia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Malaria Vaccines Market
- 14.1. South Korea Malaria Vaccines Market Overview
- 14.2. South Korea Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Malaria Vaccines Market
- 15.1. Western Europe Malaria Vaccines Market Overview
- 15.2. Western Europe Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Malaria Vaccines Market
- 16.1. UK Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Malaria Vaccines Market
- 17.1. Germany Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Malaria Vaccines Market
- 18.1. France Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Malaria Vaccines Market
- 19.1. Italy Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Malaria Vaccines Market
- 20.1. Spain Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Malaria Vaccines Market
- 21.1. Eastern Europe Malaria Vaccines Market Overview
- 21.2. Eastern Europe Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Malaria Vaccines Market
- 22.1. Russia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Malaria Vaccines Market
- 23.1. North America Malaria Vaccines Market Overview
- 23.2. North America Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Malaria Vaccines Market
- 24.1. USA Malaria Vaccines Market Overview
- 24.2. USA Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Malaria Vaccines Market
- 25.1. Canada Malaria Vaccines Market Overview
- 25.2. Canada Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Malaria Vaccines Market
- 26.1. South America Malaria Vaccines Market Overview
- 26.2. South America Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Malaria Vaccines Market
- 27.1. Brazil Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Malaria Vaccines Market
- 28.1. Middle East Malaria Vaccines Market Overview
- 28.2. Middle East Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Malaria Vaccines Market
- 29.1. Africa Malaria Vaccines Market Overview
- 29.2. Africa Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Malaria Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Malaria Vaccines Market Competitive Landscape And Company Profiles
- 30.1. Malaria Vaccines Market Competitive Landscape
- 30.2. Malaria Vaccines Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Ipca Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlaxoSmithKline Plc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Malaria Vaccines Market Other Major And Innovative Companies
- 31.1. Takeda Pharmaceutical Co Ltd.
- 31.2. Hikma Pharmaceuticals PLC
- 31.3. Amneal Pharmaceuticals LLC.
- 31.4. Lupin
- 31.5. Taj Pharmaceuticals Limited.
- 31.6. Nobelpharma Co. Ltd.
- 31.7. Bliss GVS Pharma Ltd.
- 31.8. Sanaria Inc.
- 31.9. Precigen Inc.
- 31.10. AdvaCare Pharma
- 31.11. CellFree Sciences
- 31.12. Actiza Pharmaceutical Private Limited
- 31.13. Sumaya Biotech
- 31.14. VLP Therapeutics LLC
- 31.15. GeoVax Labs Inc.
- 32. Global Malaria Vaccines Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Malaria Vaccines Market
- 34. Recent Developments In The Malaria Vaccines Market
- 35. Malaria Vaccines Market High Potential Countries, Segments and Strategies
- 35.1 Malaria Vaccines Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Malaria Vaccines Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Malaria Vaccines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.